Trial intelligence / Profile preview

Sertraline for depression in CKD

NCT00946998Phase 3Completed

Sponsor
VA Office of Research & Development
Start
Feb 2010
Primary completion
Nov 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sertraline in major depressive disorder (MDD), sponsored by VA Office of Research & Development. Started Feb 2010; status: completed.

02

Drugs

sertraline
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT00946998.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00946998.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call